BioWorld

Oct. 5, 2006

Plexxikon Enters Roche Deal On B-Raf Inhibitors For $706M

Earlier this week, Plexxikon Inc.'s president Kathleen Sereda Glaub told BioWorld Today that the company was in "active partnering mode." (BioWorld Today) Read More

Genentech, CGI In Potential $500M Kinase-Focused Deal

Killing Bacterial Gang Of Four Can Divide, Conquer Biofilms

HGS Updates Pipeline, Unveils Albuferon Phase III HCV Plans

Capitalizing On Stock Boost, Acorda Raises $32M Privately

Clinic Roundup

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...